Fertility and Sterility
Volume 94, Issue 1 , Pages 11-15 , June 2010

Human immunodeficiency virus and infertility treatment

  • The Ethics Committee of the American Society for Reproductive Medicine

Received 27 January 2010 ,Accepted 28 January 2010.

References 

  1. Ethics Committee of the American Fertility Society. Ethical considerations of assisted reproductive technologies. Fertil Steril. 1994;62(Suppl 1):85s
  2. Anderson DJ. Assisted reproduction for couples infected with the human immunodeficiency virus type 1. Fertil Steril. 1999;72:592–594
  3. Politch JA, Xu C, Tucker L, Anderson DJ. Separation of HI-1 from the motile sperm fraction: comparison of gradient/swim-up and double tube technique [abstract]. In: Abstracts of the Scientific Oral and Poster Sessions of the 57th Annual Meeting of the American Society for Reproductive Medicine, Orlando, FL, Oct. 20–25, 2001:S-49.
  4. Semprini AE, Levi-Setti P, Ravizza M, Pardi G. Assisted conception to reduce the risk of male-to-female sexual transfer of HIV in serodiscordant couples: an update [abstract]. Presented at the 1998 Symposium on AIDS in Women, Sao Paulo, Brazil, September 14–15, 1998.
  5. Semprini AE, Levi-Setti P, Bozzo M, Ravizza M, Taglioretti A, Sulpizio P, et al. Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet. 1992;340:1317–1319
  6. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173–1180
  7. Graham WJ, Newell ML. Seizing the opportunity: collaborative initiatives to reduce HIV and maternal mortality. Lancet. 1999;353:836–839
  8. Lindegren ML, Byers RH, Thomas P, Davis SF, Caldwell B, Rogers M, et al. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA. 1999;282:531–538
  9. Centers for Disease Control and Prevention. Achievements in public health. Reduction in perinatal transmission of HIV infection—United States, 1985–2005. MMWR Morb Mortal Wkly Rep. 2006;55:592–597
  10. International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1—a meta-analysis of 15 prospective cohort studies. N Engl J Med. 1999;340:977–987
  11. van Vliet A, van Roosmalen J. Worldwide prevention of vertical human immunodeficiency virus (HIV) transmission. Obstet Gynecol Surv. 1997;52:301–309
  12. Stringer JS, Rouse DJ, Goldenberg RL. Prophylactic cesarean delivery for the prevention of perinatal human immunodeficiency virus transmission: the case for restraint. JAMA. 1999;281:1946–1949
  13. Kambin S, Batzer F. Assisted reproductive technology in HIV serodiscordant couples. Sex Reprod Menopause. 2004;2:92–100
  14. Sauer MV, Wang JG, Douglas NC, Nakhuda GS, Vardhana P, Jovanovic V, et al. Providing fertility care to men seropositive for human immunodeficiency virus: reviewing 10 years of experience and 420 consecutive cycles of in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril. 2009;91:2455–2460
  15. Peckham C, Newell ML. Preventing vertical transmission of HIV infection. N Engl J Med. 2000;343:1036–1037
  16. Mandelbrot L, Heard I, Henrion-Géant E, Henrion R. Natural conception in HIV-negative women with HIV-infected partners. Lancet. 1997;349:850–851
  17. Centers for Disease Control and Prevention. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR Recomm Rep. 1999;48(RR-13):1–31
  18. American College of Obstetricians and Gynecologists. ACOG committee opinion. Routine human immunodeficiency virus screening. Obstet Gynecol. 2008;112(2 Pt 1):401–403
  19. Food and Drug Administration;. Part 1271–human cells, tissues and cellular and tissue based products; donor screening and testing, and related labeling; interim final rule 5/24/05. Federal Register, vol. 70, no. 100, May 25, 2005, Rules and Regulations. Available at: http://www.fda.gov/cber/tissue/docs.htm. Accessed March 2, 2010.
  20. Practice Committee of American Society for Reproductive Medicine, Practice Committee of Society for Assisted Reproductive Technology. 2008 guidelines for gamete and embryo donation: a Practice Committee report. Fertil Steril. 2008;90(Suppl. 5):S30–S44
  21. Centers for Disease Control and Prevention;. HIV/AIDS surveillance report, National Center for HIV, STD, and TB Prevention, Divisions of HIV/AIDS Prevention: surveillance of healthcare workers with HIV/AIDS, June 30, 2000. Available at: http://www.cdc.gov/hiv/topics/surveillance/resoucres/reports/pdf/hasr1201.pdf. Accessed March 2, 2010.
  22. Bragdon v. Abbott (1998); 524 U.S. 624, 118 S. Ct. 2196.
  23. Americans with Disabilities Act of 1990.
  24. Annas GJ. Protecting patients from discrimination—the Americans with Disabilities Act and HIV infection. N Engl J Med. 1998;339:1255–1259
  25. Practice Committee of American Society for Reproductive Medicine. Guidelines for reducing the risk of viral transmission during fertility treatment. Fertil Steril. 2008;90(Suppl. 5):S156–S162
  26. Sauer MV. American physicians remain slow to embrace the reproductive needs of human immunodeficiency virus–infected patients. Fertil Steril. 2006;85:295–297
  27. Daar ES, Daar JF. Human immunodeficiency virus and fertility care: embarking on a path of knowledge and access. Fertil Steril. 2006;85:298–300

 The members of the ASRM Ethics Committee have the following to disclose: Andrea Braverman, Ph.D., has nothing to disclose. Robert Brzyski, M.D., Ph.D., has nothing to disclose. Judith Daar, J.D., has nothing to disclose. Leslie Francis, J.D., Ph.D., has nothing to disclose. Mark Gibson, M.D., has nothing to disclose. Dolores Lamb, Ph.D., has nothing to disclose. Steven Ralston, M.D., has nothing to disclose. Robert Rebar, M.D., has nothing to disclose. John Robertson, J.D., has nothing to disclose. Andrea Stein, M.D., has nothing to disclose. Bonnie Steinbock, Ph.D., has nothing to disclose. Sean Tipton, M.A., has nothing to disclose. Brue Wilder, M.D., J.D., has nothing to disclose.

 No reprints will be available.

PII: S0015-0282(10)00152-4

doi: 10.1016/j.fertnstert.2010.01.077

Fertility and Sterility
Volume 94, Issue 1 , Pages 11-15 , June 2010

Article Tools